Related Experiment Videos
3,3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis
Lei Dong1, Suhua Xia, Fengbo Gao
1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China.
Biochemical Pharmacology
|October 27, 2009
Summary
3,3'-Diindolylmethane (DIM), a natural compound, effectively treats experimental arthritis in animal models by inhibiting RANKL, a key factor in bone resorption. This finding suggests DIM
Area of Science:
- Natural Products Chemistry
- Immunology
- Rheumatology
Background:
- 3,3 '-Diindolylmethane (DIM) is derived from glucobrassicin in Brassica vegetables.
- Arthritis involves complex inflammatory and bone-resorptive processes.
Purpose of the Study:
- To evaluate the therapeutic potential of DIM in experimental arthritis models.
- To elucidate the mechanisms underlying DIM's anti-arthritic effects, focusing on cytokine and RANKL pathways.
Main Methods:
- Adjuvant-induced arthritis (AIA) rat model for inflammation and tissue damage assessment.
- Analysis of serum cytokines and receptor activator for nuclear factor kappa B ligand (RANKL) expression.
- Mouse model of endotoxin-induced bone resorption (EIBR) and in vitro cell cultures to assess osteoclastogenesis and RANKL inhibition.
Main Results:
- DIM administration significantly reduced inflammation and tissue damage in the AIA model.
- DIM suppressed inflammatory cytokine expression but did not fully prevent arthritis development.
- DIM effectively inhibited RANKL expression, blocking osteoclastogenesis and alleviating arthritis in vivo and in vitro.
Conclusions:
- DIM exhibits anti-arthritic activity by inhibiting RANKL expression and osteoclastogenesis.
- DIM demonstrates potential as a therapeutic agent for arthritis and related bone disorders.